Download pdf - NEOADJUVANT TREATMENTS IN SURGICAL ONCOLOGY

Una vita senza ricerca non è degna di essere vissutaPlatone

CONGRESS VENUE HOTEL GIO’

2nd International Conference of Surgical OncologyPERUGIA | OCTOBER 23•24•25 | 2016

Honorary President Giuseppe Noya Congress President Prof. Annibale Donini

NEOADJUVANT TREATMENTS IN SURGICAL ONCOLOGY

SOCIETÀ ITALIANA DI CHIRURGIA ONCOLOGICA Italian Society of Surgical Oncology, ESSO affiliated

2

PATRONAGES

3

EXECUTIVE BOARD S.I.C.O.

CONGRESS BOARD S.I.C.O.

PresidentPaolo Delrio

Past President

Achille Lucio Gaspari

Next President

Domenico D’Ugo

Secretary - Treasurer

Massimo Dessena

General Secretary

Franco Roviello

Honorary PresidentGiuseppe Noya

Chairmen of the BoardAnnibale Donini General Surgery Emergency University of Perugia Tel-Fax: 39-075-5786445 e-mail: [email protected]

Scientific CommitteeDomenico D’Ugo Paolo Delrio Massimo Dessena Annibale Donini Achille Lucio GaspariLuigina Graziosi Franco Roviello

Board Members

Davide Cavaliere Alessandro Gronchi Daniele Marrelli Andrea Muratore Andrea Percivale

Onco Team CoordinatorCarlo Staudacher

Young Coordinator

Raffaele De Luca

4

CHIARMEN/SPEAKERS

Luca Aldrighetti (Milano)

Sergio Alfieri (Roma)

Gabriele Anania (Ferrara)

Luca Ansaloni (Bergamo)

Giacomo Antonini (Castiglion del Lago - Perugia)

Francesco Ardito (Roma)

Cynthia Aristei (Perugia)

Carlo Aschele (La Spezia)

Nicola Avenia (Terni)

Daniel Azoulay (Francia)

Paolo Baccari (Perugia)

Gian Luca Baiocchi (Brescia)

Gianandrea Baldazzi (Abano Terme)

Gianpaolo Balzano (Milano)

Francesco Basile (Catania)

Massimo Basti (Pescara)

Claudio Belluco (Aviano)

Pietro Paolo Bianchi (Grossetto)

Alberto Biondi (Roma)

Ugo Boggi (Pisa)

Luigi Bonavina (Milano)

Stefano Bonilauri (Reggio Emilia)

Carlo Boselli (Perugia)

Fausto Breccolotto (Perugia)

Vittorio Bresadola (Udine)

Antonio Brescia (Roma)

Riccardo Bussone (Torino)

Pietro Giorgio Calò (Cagliari)

Giovanni Capretti (Rozzano)

Corrado Carcacò (Napoli)

Paolo Carcoforo (Ferrara)

Riccardo Casadei (Bologna)

Stefano Cascinu (Modena)

Giampaolo Castagnoli (Spoleto)

Davide Cavaliere (Forlì)

Giorgio Cavallesco (Ferrara)

Emanuel Cavazzoni (Perugia)

Maurizio Cesari (Città di Castello - Perugia)

Vittorio Cherchi (Udine)

Federica Cipriani (Milano)

Roberto Cirocchi (Terni)

Claudio Coco (Roma)

Eugenio Cocozza (Varese)

Michele Camandona (Torino)

Alessandro Contine (Città di Castello - Perugia)

Giovanni Conzo (Napoli)

Andrea Coratti (Firenze)

Enrichetta Corgna (Perugia)

Piero Covarelli (Perugia)

Francesco Crafa (Napoli)

Lucio Crinò (Perugia)

Miriam Cuatrecasas (Spagna)

Maria Cristina Cucchi (Bologna)

Michele D’Ajello (Terni)

Verena De Angelis (Perugia)

Franco De Cian (Genova)

Maurizio De Giuli (Torino)

Giovanni De Manzoni (Verona)

Antonino De Paoli (Aviano)

Stefano De Pascale (Milano)

Paolo Del Rio (Prato)

Paolo Delrio (Napoli)

Marcello Deraco (Milano)

Massimo Dessena (Cagliari)

5

CHIARMEN/SPEAKERS

Franco Di Filippo (Roma)

Francesco Di Marzo (Viareggio)

Pier Luigi Di Sebastiano (Chieti)

Domenico D’Ugo (Roma)

Sara Emerenziani (Roma)

Giorgio Ercolani (Bologna)

Alessandra Fabi (Roma)

Massimo Falconi (Milano)

Alessandro Ferrero (Torino)

Marco Fiore (Milano)

Stefano Fiorucci (Perugia)

Massimo Framarini (Forlì)

Uberto Fumagalli (Milano)

Viviana Galimberti (Milano)

Alfredo Garofalo (Roma)

Carlo Garufi (Pesaro)

Gianluca Garulli (Riccione)

Achille Lucio Gaspari (Roma)

Marcello Gasparrini (Roma)

Simone Giacopuzzi (Verona)

Paolo Giovenali (Perugia)

Roberto Girelli (Peschiera)

Felice Giuliante (Roma)

Olivier Glehen (Francia)

Luigina Graziosi (Perugia)

Giovanni Grignani (Torino)

Guido Griseri (Savona)

Mario Guerrieri (Ancona)

Michele Guida (Bari)

Nino Gullà (Messina)

Giovanni B. Ivaldi (Pavia)

Francesco Izzo (Napoli)

Shigeki Kusumura (Milano)

Francesco Leone (Torino)

Alberto Liboni (Ferrara)

Roberto Lo Tesoriere (Torino)

Celestino Pio Lombardi (Roma)

Sara Lonardi (Padova)

Marcello Lucchese (Firenze)

Roberta Lucchini (Terni)

Antonio Macrì (Messina)

Giuseppe Malleo (Verona)

Pierluigi Marini (Roma)

Daniele Marrelli (Siena)

Mario Martinotti (Cremona)

Marco Massani (Treviso)

Davide Melisi (Verona)

Carlo Milandri (Empoli)

Edoardo Minciotti (Branca - Perugia)

Vincenzo Minotti (Perugia)

Simone Mocellin (Padova)

Massimo Monacelli (Perugia)

Paolo Morgagni (Forlì)

Matteo Moro (Milano)

Gianni Mura (Arezzo)

Andrea Muratore (Torino)

Roberto Murgo (San Giovanni Rotondo)

Giuseppe Navarra (Messina)

Donato Nitti (Padova)

Andrea Oddi (Roma)

Elena Orsenigo (Milano)

Diamante Pacchiarini (Perugia)

Maria Teresa Paganelli (Perugia)

Raffele Palaia (Napoli)

6

FRAY, 11TH SEMBER 2015 CHIARMEN/SPEAKERS

Giovanni Pallabazzer (Pisa)

Dante Palli (Parma)

Vincenzo Panebianco (Taormina)

Francesco Papadia (Genova)

Amilcare Parisi (Terni)

Enrico Maria Pasqual (Udine)

Daniela Pasquali (Napoli)

Alberto Patriti (Perugia)

Maurizo Pavanello (Asolo)

Riccardo Pellicci (Savona)

Elisabetta Pennacchioli (Milano)

Andrea Percivale (Savona)

Pasquale Perri (Roma)

Roberto Persiani (Roma)

Filippo Pietrantonio (Milano)

Andrea Polistena (Perugia)

Alfredo Pontecorvi (Roma)

Fernando Prete (Bari)

Eugenio Procaccini (Napoli)

Salvatore Pucciarelli (Padova)

Efisio Puxeddu (Perugia)

Vincenzo Quagliuolo (Milano)

Stefano Rausei (Varese)

Andrea Risaliti (Udine)

Manuela Robella (Torino)

Fausto Roila (Terni)

Giovanni Romano (Napoli)

Fabio Rondelli (Perugia)

Riccardo Rosati (Milano)

Carlo Rossi (Padova)

Franco Roviello (Siena)

Antonio Rulli (Perugia)

Alberto Ruol (Padova)

Roberto Salvia (Verona)

Sergio Sandrucci (Torino)

Alessandro Sanguinetti (Terni)

Cinzia Sassaroli (Napoli)

Stefano Scabini (Genova)

Stefano Scaringi (Firenze)

Marco Scatizzi (Prato)

Salvatore Sorrenti (Roma)

Giovanni Sgroi (Treviglio)

Angelo Sidoni (Perugia)

Nicola Silvestris (Bari)

Michele Simone (Bari)

Nicola Solari (Genova)

Antonio Sommariva (Padova)

Mario Taffurelli (Bologna)

Mario Testini (Bari)

Alessandro Testori (Milano)

Guido Alberto Massimo Tiberio (Brescia)

Giovanni Antonio Tommaselli (Roma)

Stefano Turi (Milano)

Paolo Ubiali (Pordenone)

Marco Vaira (Torino)

Vincenzo Valentini (Roma)

Mario Valle (Roma)

Christian Wittekind (Germania)

Alberto Zaniboni (Brescia)

Alessandro Zerbi (Rozzano)

Costantino Zingaretti (Pesaro)

7

FRAY, 11TH SEPER 2015 CHAIRMEN/SPEAKERS YOUNG SICO SESSION

Francesco Ardito (Roma)

Maria Astorino, (Grosseto)

Claudio Belluco (Aviano-Pordenone)

Maria Bencivenga (Verona)

Pietro Paolo Bianchi (Grosseto)

Davide Cavaliere (Forli)

Coco Claudio (Roma)

Andrea Cossu (Milano)

Lorenzo De Franco (Siena)

Maurizio De Giuli (Torino)

Raffaele De Luca (Bari)

Matteo Donadon (Rozzano-Milano)

Ugo Elmore (Milano)

Giorgio Ercolani (Forli)

Giulia Fiore (Siena)

Giampaolo Formisano (Grosseto)

Matteo Frasson (Valencia)

Gaetano Gallo (Catanzaro)

Maria Antonietta Gambacorta (Roma)

Daniela Greto (Firenze)

Francesco Izzo (Napoli)

Maddalena Leongito (Napoli)

Laura Lorenzon (Roma)

Francesco Maione (Napoli)

Luigi Marano (Spoleto)

Mario Marini (Siena)

Daniele Marrelli (Siena)

Alfredo Mellano (Candiolo-Torino)

Riccardo Memeo (Acquaviva delle Fonti - Bari)

Annalisa Milano (Milano)

Marco Milone (Napoli)

Pasquale Misitano (Grosseto)

Armando Orlandi (Roma)

Ugo Pace (Napoli)

Alberto Patriti (Spoleto)

Andrea Percivale (Pietra Ligure)

Karol Polom (Posznan (Pl))

Fernando Prete (Acquaviva delle Fonti - Bari)

Salvatore Pucciarelli (Padova)

Francesca Ratti (Milano)

Stefano Rausei (Varese)

Daniela Rega (Napoli)

Angelo Restivo (Cagliari)

Gianluca Rizzo (Napoli)

Giandomenico Roviello (Brescia)

Francesco Ruotolo (Roma)

Andrea Ruzzenente (Verona)

Edoardo Saladino (Messina)

Lucia Salvischiani (Grosseto)

Dario Scala (Napoli)

Michele Simone (Bari)

Vincenzo Simonelli (Lussemburgo)

Jacopo Weindelmayer (Verona)

8

SUNDAY, OCTOBER 23rd 2016TRUMPET HALL 1

13.00 17.30

PRE-CONGRESS SYMPOSIUM YOUNG SICO

18.30 INAUGURAL CEREMONY Palazzo Bernabei - Assisi

MONDAY, OCTOBER 24th 2016TOWN HALL TRUMPET HALL 1 TRUMPET HALL 2

08.30 10.30

SIEWERT II/III ADENOCARCINOMA OF THE ECG: OPEN PROBLEMS

NEOADJUVANT THERAPY IN BREAST CANCER

CHALLENGING SCENARIOS IN COLORECTAL LIVER METASTASIS

10.30 12.30

NEOADJUVANT CHEMOTHERAPY (NAC) IN GASTRIC CANCER

NEOADJUVANT THERAPY OF CUTANEOUS MELANOMA

VIDEO SESSION LIVER SURGERY

12.30 13.00

13.00 14.30

AWARDS CEREMONY LUANA RICCA

LUNCHTIME LECTURES

14.30 16.30

GASTRIC CANCER PERITONEAL CARCINOMATOSIS: HOW DO WE TREAT IT?

ERAS IN GASTRONINTESTINAL CANCER

MEDULLARY THYROID CARCINOMA: UP DATE ON DIAGNOSTIC AND MULTI-DISCIPLINARY TREATMENT

16.30 18.30

MINIINVASIVE SURGERY IN GASTRIC CANCER’S TREATMENT

OSNA AND CLINICAL APPLICATION IN GASTROINTESTINAL TUMOURS

COURSE ON MULTIDISCIPLINARY EVALUATION OF GASTROINTESTINAL CANCER

PLENARY ROOM - TOWN HALL

18.30 19.30

SICO GENERAL ASSEMBLY

SYNOPTIC TABLE

9

TUESDAY, OCTOBER 25th 2016TOWN HALL TRUMPET HALL 1 TRUMPET HALL 2

08.30 10.30

RECTAL CANCER: NEOADJUVANT

NEOADJUVANT STRATEGIES IN SOFT TISSUE SARCOMA AND GIST

NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMA

10.30 12.30

PREVENTION OF SURGICAL SITE INFECTION

Y-SICO ACTIVITY FUTURE PLANS & STUDY PROPOSAL

SESSION 2 VIDEO

12.30 13.00

13.00 14.30

AWARDS CEREMONYFONDAZIONE GUIDO BERLUCCHI

LUNCHTIME LECTURES

14.30 16.30

COLON CANCER PERITONEAL CARCINOMATOSIS: CLINICAL EVIDENCES

Selected communications: UPPER GI

Selected Communications:

COLORECTAL CANCER AND PERITONEAL CARCINOMATOSIS

16.30 18.30

MINIINVASIVE SURGERY IN THE TREATMENT OF CO-LON CANCER

SYNOPTIC TABLE

10

SUNDAY, OCTOBER 23rd 2016

13.00 - 17.30 PRE-CONGRESS SYMPOSIUM YOUNG SICOTRUMPET 1 HALL HOTEL GIÒ - PERUGIA

Event Coordinators: Y-SICO BOARD R. De Luca, D. Rega, M. Bencivenga, L. De Franco, M. Leongito, A. Mellano M. Milone, E. Saladino

UPPER GICoordinator: M. Bencivenga, L. De Franco, M. Milone Senior Chairman: M. Simone Young Chairmen: M. Bencivenga, M. Milone 13.00 Surgical Anatomy

F. Ruotolo 13.15 Ivor Lewis by open approach

J. Weindelmayer13.25 D2 Gastrectomy by open approach

K. Polom13.45 Laparoscopic D2 Gastrectomy

A. Cossu13.55 Gastric Robotic Surgery

L. Marano14.05 Surgical management of esophageal-jejunal leakage

L. De FrancoExpert Discussant: M. De Giuli, U. Elmore, D. Marrelli 14.15 Debate-take home message

COLORECTAL SESSIONCoordinator: R. De Luca, A. Mellano, D. RegaSenior Chairman: F. Prete Young Chairmen: R. De Luca, D. Rega 14.30 Surgical Anatomy

F. Ruotolo14.45 Right Colectomy Open & laparoscopic approach

V. Simonelli 14.55 Left Colectomy Open & laparoscopic approach

G. Gallo

11

SUNDAY, OCTOBER 23rd 2016

15.05 Splenic flexure cancer: robotic surgical approach L Salvischiani

15.15 Laparoscopic TME M. Milone

15.25 Rectal cancer by TA-TME approach A. Mellano

15.35 Abdominoperineal Amputation & pelvic floor reconstruction M. Frasson

Expert Discussant: D. Cavaliere, A. Restivo, D. Scala15.45 Debate-take home message

HEPATIC SESSIONCoordinator: M. Leongito, E. Saladino Senior Chairman: F. Izzo Young Chairmen: M. Leongito, E. Saladino 16.00 Surgical Anatomy

F. Ruotolo 16.15 Liver intraoperative ultrasound: role and indication

M. Donadon 16.25 Right Hepatectomy by open approach

F. Ardito 16.35 Right Hepatectomy by laparoscopic approach

F. Ratti 16.45 Left Hepatectomy/ Left Lobectomy by open approach

A. Ruzzenente 16.55 Left hepatectomy/left lobectomy by laparoscopic approach

R. Memeo 17.05 Posterior Hepatic Segmentectomy by robotic approach

A. Patriti Expert discussant: G. Ercolani, A. Percivale, M. Simone 17.15 Debate-take home message

OPENING CEREMONY 18.30 Palazzo Bernabei - Assisi

12

MONDAY, OCTOBER 24th 2016

PLENARY ROOM TOWN HALL

8.30 - 10.30 SIEWERT II/III ADENOCARCINOMA OF THE ECG: OPEN PROBLEMSChairmen: G. De Manzoni, V. Minotti, A. Zaniboni 8.30 8th AJCC-UICCTNM Classification: nodal Involvement and Choice

of Lymphadenectomy S. Giacopuzzi

8.45 Siewert II: Type of Resection: Total Gastrectomy or Subtotal Esophagectomy R. Rosati

9.00 Neoadjuvant Treatment: Chemoradiotherapy? Chemotherapy? A. Zaniboni

9.15 Molecular biomarkers of response to neoadjuvant treatments in EGJ adenocarcinoma D. Melisi

9.30 Stage IV without peritoneal carcinomatosis: is there space for Conversion Surgery? G. Pallabazzer

9.45 - 10.05 Selected CommunicationsCROSS REGIMEN FOR ESOPHAGEAL CANCER: SINGLE CENTER EXPERIENCE Puccetti F.*[1], De Pascale S.[1], Garassino I.[1], Cavina R.[1], Tozzi A.[1], Fumagalli U.[1], Rosati R.[2] [1]IRCCS Humanitas Research Hospital ~ Rozzano (MI) ~ Italy, [2]IRCCS San Raffaele Hospital ~ Milano ~ Italy

ROBOTIC ESOPHAGECTOMY: OUR EXPERIENCE AND PRELIMINARY RESULTS Bartolini I.*, Vegni A., Annecchiarico M., Bencini L., Moraldi L., Di Marino M., Pesi B., Coratti A. aou careggi ~ Firenze ~ Italy10.05 DiscussionDiscussants: L. Bonavina, M. Camandona, A. Ruol

10.30 - 12.30 NEOADJUVANT CHEMOTHERAPY (NAC) IN GASTRIC CANCERChairmen: E. Orsenigo, F. Roviello10.30 Evidences and controversies from Literature

M. De Giuli10.45 NAC in gastric cancer: Who may benefit

S. Rausei11.00 NAC in gastric cancer: preoperative or perioperative?

P. Morgagni

13


11.15 Different CHT protocols in NAC for GC C. Milandri

11.30 Surgical implications after NAC D. Marrelli

11.45 - 12.05 Selected CommunicationsROLE OF EXETENDED LYMPHADENECTOMY IN GASTRIC CANCER SURGERY: A RETROSPECTIVE SINGLE CENTRE EXPERIENCE Lomonaco R.[1], De Luca R.[1], Caliandro C.[1], Ruggieri E.[1], Nannavecchia A.[2], Rucci A.[1], Ammendola M.*[3], Simone M.[1]

[1]National Cancer Research Centre “G.Paolo II” Istituto Tumori ~ BARI ~ Italy, [2]Puglia Cancer Registry ~ Bari ~ Italy, [3]Clinical Surgery Unit.University of “Magna Grecia” ~ Catanzaro ~ Italy

MIR375 EXPRESSION AND DIFFUSE-TYPE GASTRIC CANCERSAvantifiori R.*[1], Lorenzon L.[1], Mercantini P.[1], Cippitelli C.[2], Uccini S.[2], French D.[2], Torrisi M.R.[2], Canu V.[3], Blandino G.[3], Cavallini M.[1]

[1]Surgical and Medical Department of Traslational Medicine, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Sant’Andrea Hospital of Rome, Italy ~ Rome ~ Italy, [2]Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Sant’Andrea Hospital of Rome, Italy ~ Rome ~ Italy, [3]Translational Oncogenomic Unit, Italian National Cancer Institute Regina Elena, Rome, Italy ~ Rome ~ Italy12.05 DiscussionDiscussants: R. Palaia, V. Panebianco, R. Persiani

12.30 - 13.00 AWARDS CEREMONY LUANA RICCA

LUNCHTIME LECTURES: 13.00 Surgery in liver colorectal metastases

D. Azoulay13.45 Satellite Session

Electrochemotherapy: Meet the expert F. Izzo

14.30 -16.30 GASTRIC CANCER PERITONEAL CARCINOMATOSIS: HOW DO WE TREAT IT?Chairmen: V. De Angelis, A. Garofalo14.30 Adjuvant HIPEC in Locally AGC

L. Ansaloni14.45 GASTRICHIP: preliminary results

O. Glehen

14


15.15 Therapeutic HIPEC F. Roviello

15.30 Extensive Lavage L. Graziosi

15.45 - 16.00 Selected CommunicationsHYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) AND NEOADJUVANT CHEMOTHERAPY AS PROPHYLAXIS OF PERITONEAL CARCINOSIS FROM ADVANCED GASTRIC CANCER—EFFECTS ON OVERALL AND DISEASE FREE SURVIVALCoccolini F., Celotti A., Ceresoli M., Montori G.*, Fugazzola P., Ansaloni L.ospedale papa giovanni 23 ~ Bergamo ~ Italy16.00 DiscussionDiscussants: A. Macrì, S. Scaringi, M. Valle

16.30 - 18.30 MINIINVASIVE SURGERY IN GASTRIC CANCER TREATMENTChairmen: D. D’Ugo, G. Tiberio16.30 Laparoscopic total gastrectomy surgical technique

A. Biondi16.50 Laparoscopic subtotal gastrectomy surgical technique

G. Sgroi17.10 Laparoscopic D2 Lymphadenectomy in gastric cancer surgery

E. Cocozza17.30 Robotic approach in gastric cancer surgery

A. Coratti17.50 - 18.10 Selected CommunicationsLYMPH NODE DISSECTION GUIDED BY INDOCYANINE GREEN FLUORESCENCE IMAGING DURING ROBOTIC SURGERY FOR GASTRIC CANCER Staderini F.*[1], Foppa C.[1], Indennitate G.[3], Badii B.[1], Novelli L.[2], Paoli B.[3], Ortolani M.[3], Skalamera I.[1], Qirici E.[1], Perigli G.[1], Cianchi F.[1]

[1]Center of Oncological Minimally Invasive Surgery (COMIS), Department of Surgery and Translational Medicine, University of Florence, Italy ~ Florence ~ Italy, [2]Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy ~ Florence ~ Italy, [3]IFCA ~ Florence ~ Italy

TOTALLY MINIMALLY INVASIVE VS HYBRID ESOPHAGECTOMY FOR CANCER: A COMPARATIVE PROSPECTIVE STUDY ON SAFETY AND EFFICACY.Melis A.*, Parise P., Incarbone N., Adamenko O., Mazza M., Giannone F., Cossu A., Rosati R.San Raffaele Hospital ~ Milano ~ Italy18.10 DiscussionDiscussants: C. Boselli, M. Cesari, M. Scatizzi)

18.30 - 19.30 SICO GENERAL ASSEMBLY

15


TRUMPET HALL 1

8.30 - 10.30 NEOADJUVANT THERAPY IN BREAST CANCER Chairmen: P. Carcoforo, A. Fabi, R. Murgo 8.30 Italian Survey

M. Dessena8.45 Dedicated Diagnostic Therapeutic Care Pathways:

M. Taffurelli9.00 The future of therapy for HER2+ patients

A. Fabi9.15 Axillary-Conserving Surgery:

V. Galimberti9.30 Mastectomy after NAC

M.C. Cucchi9.45 Radiotherapy

G.B. Ivaldi10.00 - 10.20 Selected CommunicationsFEASIBILITY OF LYMPHOSCINTIGRAPHY FOR SENTINEL NODE IDENTIFICATION AFTER NEO-ADJUVANT THERAPYCorso G.*[1], Vicina E.[1], Baio S.M.[2], Gilardi L.[2], Maisonneuve P.[3], Grana C.M.[2], Galimberti V.[1]

[1]Division of Senology, European Institute of Oncology ~ Milan ~ Italy, [2]Division of Nuclear Medicine, European Institute of Oncology ~ Milan ~ Italy, [3]Division of Epidemiology and Biostatistics, European Institute of Oncology ~ Milan ~ Italy

THE ROLE OF NEOADJUVANT CHEMOTERAPY IN CHOOSING THE TYPE OF SURGERY IN BREAST CANCER HER2+ AND TRIPLE NEGATIVE.Calderoni S.*[1], Brulatti M.[1], Cuoghi M.[1], Galluzzo V.[1], Ferrarini R.[1], Zanarini D.[1], Cucchi M.C.[2]

[1]Breast Unit Ospedale Bellaria ~ BOLOGNA ~ Italy, [2]Direttore Breast Unit Ospedale Bellaria ~ BOLOGNA ~ Italy10.20 Discussion Discussants: R. Bussone, D. Palli, P. Perri, E. Procaccini

10.30 - 12.30 NEOADJUVANT THERAPY OF CUTANEOUS MELANOMA Chairmen: A. Testori, C. Caracò10.30 Target and immunotherapy in advanced melanoma treatment

E. Corgna 10.45 Neoadjuvant target therapy in advanced melanoma treatment

C. Caracò

16


11.00 Neoadjuvant immunotherapy with check point inhibitors in advanced melanoma S. Mocellin

11.15 Isolated limbs perfusion: could it be considered as a neoadjuvant therapy? Our experience and results. F. Papadia

11.30 Surgery after stage II-III and IV neoadjuvant therapies A. Testori

11.45 - 12.00 DiscussionDiscussants: P. Covarelli, M. Guida, C. Rossi, N. Solari, A. Sommariva

LUNCHTIME

14.30 - 16.30 ERAS IN GASTRONINTESTINAL CANCERChairmen: U. Fumagalli, A. Brescia 14.30 ERAS in Gastric Cancer

S. De Pascale14.45 Eras in esophageal cancer

R. Rosati15.00 Eras in colorectal cancer

M. Gasparrini15.15 Anesthesiologist’s perspectives

S. Turi15.30 - 15.50 Selected communicationsIMPACT OF EXPERIENCE IN ENHANCED RECOVERY AFTER SURGERY (ERAS) FOR ESOPHAGEAL SURGERYWeindelmayer J.*[1], Giacopuzzi S.[1], Zanoni A.[2], Gobbi L.[1], De Pasqual C.A.[1]

[1]Upper GI surgery AOUI B.go Trento ~ Verona ~ Italy, [2]Chirurgia generale ~ Rovereto ~ Italy

ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN GASTRIC SURGERY FOR CANCER: REVIEW OF A SINGLE INSTITUTION EXPERIENCE.Cossu A.*, Parise P., Melis A., Giannone F., Mazza M., Adamenko O., Elmore U., Rosati R.Division of Gastrointestinal Surgery, San Raffaele Hospital IRCCS ~ Milano ~ Vanuatu15.50 DiscussionDiscussants: A. Contine, S. Emerenziani, M.T. Paganelli

16.30 - 18.30 OSNA AND CLINICAL APPLICATION IN GASTROINTESTINAL TUMOURS Chairmen: S. Fiorucci, P. Giovenali, A. Rulli, A. Sidoni 16.30 Molecular Staging in Colon Cancer

M. Cuatrecasas17.15 Sentinel node in colorectal Rectal cancer

F. Crafa

17


17.45 The use of OSNA Nomogram in the decision treatment algorithm of breast cancer patients with positive SLN F. Di Filippo

18.15 - 18.25 Selected communicationTHE USE OF ONE-STEP NUCLEIC ACID AMPLIFICATION (OSNA) FOR INTRAOPERATIVE DETECTION OF LYMPH NODE METASTASIS IN BREAST CANCER PATIENTS. PRELIMINARY DATA FROM A RETROSPECTIVE STUDY OF 56 CASES.Salaris C.*, Sanna S., Medas F., Gordini L., Podda F., Tatti A., Calò P.G.Policlinico Universitario ~ Monserrato (CA) ~ Italy18.25 Discussion

18


TRUMPET HALL 2

8.30 - 10.30 CHALLENGING SCENARIOS IN COLORECTAL LIVER METASTASISChairmen: C. Garufi, R. Pellicci 8.30 CCR with liver only metastasis: what is the optimal neoadjuvant regimen?

C. Aschele8.45 How to increase resectability of colorectal liver metastasis?

A. Ferrero9.00 What is the impact of preoperative chemotherapy

on resectability ? F. Giuliante

9.15 How to manage the “Vanishing Lesions” L. Aldrighetti

9.30 Impact of HAI on chemotherapy regimen in the treatment of colorectal liver metastasis M. Massani

9.45 - 10.05 Selected Communications

ROLE OF R1 LIVER RESECTIONS FOR COLORECTAL METASTASES IN THE ERA OF MODERN CHEMOTHERAPYFerrucci M.*, Ardito F., Coppola A., Panettieri E., Vellone M., Giuliante F.Università Cattolica del Sacro Cuore - Policlinico “A. Gemelli” ~ Roma ~ Italy

CEACAM5 MRNA IN BLOOD AS PROGNOSTIC BIOMARKER OF EARLY RECURRENCE IN LIVER METASTATIC COLORECTAL CANCER PATIENTSPanettieri E.*[1], Ardito F.[1], Giuliante F.[1], Mele C.[1], Vellone M.[1], Pocino K.[2], Autilio C.[2], Paolillo C.[2], Capoluongo E.[2]

[1]Catholic University, Hepatobiliary Surgery Unit ~ Rome ~ Italy, [2]Catholic University, Laboratory of Clinical Molecular and Personalized Diagnostics ~ Rome ~ Italy10.05 DiscussionDiscussants: G. Ercolani, G. Griseri, F. Leone A. Percivale

10.30 - 12.30 VIDEO SESSION - LIVER SURGERYChairmen: D. Azoulay, A. Risaliti10.30 Complex lap liver resections for colorectal mets: pushing the limits

F. Cipriani10.50 Laparoscopic two-stage hepatectomy for multiple bilateral colorectal metastases

R. Lo Tesoriere 11.10 Two stage hepatectomy with occlusion of left portal vein and of right anterior

portal vein F. Ardito

19


11.30 Major hepatectomy by means of linear stapler Alpps V. Cherchi

11.50 Video Filauro

Discussants: E. Cavazzoni, R. Cirocchi , A. PatritiLUNCHTIME

14.30 - 16.30 MEDULLARY THYROID CARCINOMA: UPDATE ON DIAGNOSTIC AND MULTIDISCIPLINARY TREATMENT

Chairmen: A. Pontecorvi, M. Testini 14.30 Update on diagnosis of medullary thyroid carcinoma

P. Del Rio14.45 Genetics of medullary thyroid carcinoma

D. Pasquali15.00 Medullary thyroid carcinoma: Prophylactic treatment: When and how

C.P. Lombardi15.15 Surgical treatment of medullary thyroid carcinoma: What Lymphectomy?

N. Avenia15.30 The role of new drugs in medical treatment of medullary thyroid carcinoma

E. Puxeddu15.45 - 16.05 Selected CommunicationsCENTRAL NECK DISSECTION IN CLINICALLY NODE-NEGATIVE PATIENTS WITH DIFFERENTIATED THYROID CANCER: WHERE ARE WE NOW? A CRITICAL ANALYSIS OF OUR EXPERIENCE Podda F.*, Gordini L., Medas F., Tatti A., Erdas E., Pisano G., Calò P.G. Department of Surgical Sciences - University of Cagliari ~ Cagliari ~ ItalyUNDETERMINED NODULES (THY3) AND THYROID CARCINOMA: A CRITICAL ANALYSIS OF OUR EXPERIENCE Gordini L.*, Medas F., Podda F., Salaris C., Pisano G., Erdas E., Calò P.G. Department of Surgical Sciences - University of Cagliari ~ Cagliari ~ Italy16.05 DiscussionDiscussants: P.G. Calò, G. Conzo, M. D’Ajello, R. Lucchini, M. Monacelli, A. Polistena, A. Sanguinetti, S. Sorrenti

16.30 - 18.30 COURSE ON MULTIDISCIPLINARY EVALUATION OF GASTROINTESTINAL CANCER16.30 Lecture: Organization and relevance of the multidisciplinary

team for the evaluation and treatment of gastrointestinal cancer. D. Greto

16.40 Comment of A. Milano

20


Updates on Locally Advanced Gastric CancerSenior Chairman: D. Marrelli Young Chairman: M. Bencivenga, A. Mellano Opinion of:16.45 Endoscopist: Endoscopic Ultrasound and Staging Laparoscopy

G. Fiore 16.50 Oncologist: Neoadjuvant Chemo-Therapy

G. Roviello 16.55 Surgeon: Role of Surgery

L. De Franco Expert Discussant: M. De Giuli, M. Marini, S. Rausei

Updates on Stage IV Colon CancerSenior Chairman: P.P. Bianchi Young Chairman: M. Milone, D. Rega Opinion of:17.20 Oncologist: Neoadjuvant Chemo-Therapy

M. Astorino 17.30 Endoscopist: Treatment of stenotic cases

F. Maione 17.40 Surgeon: Details on Resection of Primary Tumor

G. Formisano 17.45 Surgeon: Timing of Colorectal Cancer Liver Metastases’ Resection

P. Misitano Expert Discussant: D. Cavaliere, U. Pace, C. Belluco

Updates on Stage IV Rectal CancerSenior Chairman: C. Coco Young Chairman: R. De Luca, E. Saladino Opinion of:18.00 Oncologist: Induction Chemo-Therapy

A. Orlandi 18.10 Radiotherapist: Standard of Neoadjuvant Radio-Therapy

A. Gambacorta 18.20 Surgeon: Treatment of Primary Tumor and the Role of Organ Preservation

G. Rizzo 18.30 Surgeon: Resectability of Hepatic Metastases

F. Ardito Expert Discussant: S. Pucciarelli, D. Scala, D. Cavaliere

21

TUESDAY, OCTOBER 25th 2016

PLENARY ROOM TOWN HALL

8.30 - 10.30 RECTAL CANCER: NEOADJUVANT Chairmen: P. Marini, D. Nitti, V. Valentini 8.30 Is neoadjuvant therapy always required for clinical stages II-III rectal cancer?

P. Delrio8.45 Management of asymptomatic stage IV rectal cancer

S. Cascinu9.00 Rectum Sparing approaches after neoadjuvant therapy

C. Coco9.15 Transanal TME after neoadjuvant therapy

A. Muratore9.30 RESARCH Study

S. Pucciarelli9.45 - 10.05 Selected CommunicationsPROGNOSTIC VALUE OF THE NUMBER OF RETRIEVED LYMPH NODES IN NODE NEGATIVE PATIENTS WHO UNDERWENT NEOADJUVANT CHEMORADIATION THERAPY OR RADIATION THERAPY ALONE. RESULTS OF THE ITALIAN COLORECTAL ONCOTEAM MULTICENTRE STUDY. M. Degiuli for the Italian Colorectal Oncoteam

FACTORS INFLUENCING LYMPH NODE YIELD IN COLORECTAL CANCERLuperto M.*, Gasparini G., Orsenigo E., Carlucci M.San Raffaele Hospital ~ Milan ~ Italy10.05 DiscussionDiscussants: C. Aristei, C. Belluco, A. De Paoli,, S. Lonardi, F. Prete, G. Romano

11.00 - 12.30 SYMPOSIUM PREVENTION OF SURGICAL SITE INFECTIONChairmen: M G. Cavallesco, M. Lucchese, D. Pacchiarini 11.00 Healthcare Associated Infections (HCAI): incidence and economic impact

M. Moro 11.40 Infection Prevention in the neoplastic patient

F. Di Marzo 12.00 Bundle of care: evalutation, effectiveness and clinical evidence

G.A. Tommaselli (Relazione non accreditata ECM)12.20 Conclusions and key messagges

12.30 - 13.00 AWARDS CEREMONY FONDAZIONE GUIDO BERLUCCHI

22


LUNCHTIME LECTURES: 13.00 Principles of Tnm Staging After Neo-Adjuvant Treatments

C. Wittekind13.30 Colorectal Carcinomatosis: Cytoreductive Surgery and HIPEC as a standard

of treatment O. Glehen

14.30 - 16.30 COLON CANCER PERITONEAL CARCINOMATOSIS: CLINICAL EVIDENCES

Chairmen: L. Crinò, O. Glehen, M. Vaira 14.30 Adjuvant HIPEC in Locally ACC

M. Deraco14.45 Therapeutic HIPEC

M. Robella Surgical point of view F. Pietrantonio Oncologist’s point of view

15.15 Hipec in rectal cancer C. Sassaroli

15.30 Learning Curve and Surgical Performance of Cytoreductive Surgery and HIPEC S. Kusamura

15.45 - 16.05 Selected CommunicationsEVALUATION OF THE SHORT-TERM OUTCOME OF CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY USED IN THE TREATMENT OF COLO-RECTAL CARCINOMATOSIS: A MULTI-INSTITUTIONAL STUDYMacrì A.*[1], Saladino E.[2]

[1]Department of Human Pathology ~ Messina ~ Italy, [2]Casa di cura Cappellani-Giomi ~ Messina ~ ItalyAuthorship: Antonio Macrì1, Vincenzo Arcoraci2, Claudia Giardina2, Valerio Belgrano3, Marina Caldana4, Tommaso Cioppa5, Franco De Cian3, Giovanni De Manzoni4, Michele De Simone6, Angelo Di Giorgio7, Francesca Muffatti8, Elena Orsenigo8, Manuela Robella6, Franco Roviello5, Paolo Sammartino7, Marco Vaira6, Saladino Edoardo9

Affiliation and address of each author: Antonio Macrì: 1Department of Human Pathology, University of Messina, Italy; Vincenzo Arcoraci, Claudia Giardina: 2Department of Clinical and Experimental Medicine, University of Messina, Italy; Franco De Cian, Valerio Belgrano: 3De-partment of Surgery, University of Genoa, Italy; Giovanni De Manzoni, Marina Caldana: 41st Department of General Surgery, University of Verona, Italy; Franco Roviello, Tommaso Cioppa: 5Department of Medicine, Surgery and Neuroscience, University of Siena, Italy; Michele De Simone, Marco Vaira, Manuela Robella: 6Department of Surgical Oncology, Candiolo Cancer Insitute, Italy; Angelo Di Giorgio, Paolo Sammartino: 7Department of Surgery “Pietro Valdoni”, University “Sapienza” of Rome, Italy; Elena Orsenigo, Francesca Muffatti: 8Department of Surgery, San Raffaele Scientific Institute, Milan, Italy; Edoardo Saladino: 9Casa di Cura Cappellani-GIOMI, Messina, Italy.

23


OVERALL AND DISEASE-FREE SURVIVAL IN PATIENTS TREATED WITH CRS PLUS HIPEC FOR PERITONEAL CARCINOMATOSIS FROM COLORECTAL AND APPENDICEAL CANCER: AN UPDATE OF OUR EXPERIENCE.Fugazzola P.*, Montori G., Coccolini F., Ceresoli M., Ansaloni L.ospedale papa giovanni 23 ~ bergamo ~ Italy16.05 Discussion Discussants: D. Cavaliere, M. Framarini, E.M. Pasqual

16.30 - 18.30 MINIINVASIVE SURGERY IN THE TREATMENT OF COLON CANCERChairmen: G. Anania, F. Basile, M. Basti16.30 TATME

R. Persiani16.45 Mini-invasive surgical approach in left colon cancer

G. Baldazzi17.00 Robotic approach: evidence from literature

P.P. Bianchi17.15 Transanal Endoscopic Microsurgery

M. Guerrieri17.30 Technological Innovations in right colon cancer surgical approach

G. Navarra17.45 Transverse colectomy: mini-invasive surgical approach

M. Pavanello18.00 - 18.20 Selected CommunicationsTHE NEW VIEW OF SURGICAL ONCOLOGY: LAPAROSCOPIC 3D TECHNOLOGY USE IN COLON CANCERMassimiliano Z.*, Alessandro V., Giuseppe P., Valentino F.Hospital of Cittadella ~ Cittadella, Padua ~ Italy

ROBOTIC TOTAL MESORECTAL EXCISION: 3-YEAR ONCOLOGICAL OUTCOMES AND SUB-GROUP ANALYSIS OF PATIENTS SUBMITTED TO NEOADJUVANT CHEMORADIOTHERAPYFormisano G.*[1], Giuliani G.[1], Misitano P.[1], Coratti F.[1], De Luca M.[1], Krizzuk D.[1], Petz W.[2], Bianchi P.P.[1]

[1]MISERICORDIA HOSPITAL ~ Grosseto ~ Italy, [2]European Institute of Oncology ~ Milan ~ Italy

18.20 Discussion Discussants: G. Antonini, F. Breccolotto, N. Gullà, F. Rondelli

24


TRUMPET HALL 1

8.30 - 10.30 NEOADJUVANT STRATEGIES IN SOFT TISSUE SARCOMA AND GISTChairmen: V. Quagliuolo, F. Roila8.30 Is there any standard approach to neoadjuvant chemotherapy in STS?

G. Grignani8.45 Decision-making and management of preoperative treatments

for rare tumors within a national collaborative network M. Fiore

9.00 Neoadjuvant radiation therapy in STS: when it is needed, when it is not A. De Paoli

9.15 Neoadjuvant TKIs in GIST: evolving indications D. Cavaliere

9.30 - 9.50 Selected CommunicationsADHERENCE TO GUIDELINES AND QUALITY OF TREATMENT OF RETROPERITONEAL SARCOMAS: A RETROSPECTIVE REGIONAL ANALYSIS IN ITALY Ponzetti A.[2], Gianotti C.[1], Mistrangelo M.[2], Siatis D.[3], Giovanni G.[4], Di Cuonzo D.[5], Ciccone G.[5], Sandrucci S.*[1] [1]Visceral Sarcoma Unit, City of Health and Science University Hospital ~ Torino ~ Italy, [2]

Oncology Department, City of Health and Science University Hospital ~ Torino ~ Italy, [3]

Division of Surgical Oncology, Candiolo Cancer Institute-FPO- IRCCS, Candiolo ~ Torino ~ Italy, [4]Division of Medical Oncology, Candiolo Cancer Institute-FPO- IRCCS, Candiolo ~ Torino ~ Italy, [5]Cancer Epidemiology Unit, CPO Piemonte ~ Torino ~ ItalyISOLATED LIMB PERFUSION FOR THE MANAGEMENT LIMB THREATENING SOFT TISSUE SARCOMAS: THE ROLE OF HISTOLOGICAL TYPE ON CLINICAL OUTCOMES Rastrelli M.*, Tropea S., Mocellin S., Rossi C.R. IOV ~ Padova ~ Italy9.50 DiscussionDiscussants: F. De Cian, E. Pennacchioli, A. Oddi, S. Sandrucci

10. 30 - 12.30 Y-SICO ACTIVITY - FUTURE PLANS & STUDY PROPOSALPresident: D. Marrelli Chairmen: R. De Luca, M. Bencivenga10.30 One Year Y-Sico Activity

D. Rega 10.35 Y. Sico&Eysac: A Strong Partnership and New Perspectives

L. Marano, L. Lorenzon, R. Memeo, K. Polom 10.40 Y. Sico Future Perspectives: Training, Fellowship, Courses

A. Mellano

25


10.55 National Audit On Rectal Cancer Patients with Complete Response After Neo-Adjuvant Therapy E An Investigation On Behalf Of The Young Italian Society Of Surgical Oncology (Y-S.I.C.O.) L. Lorenzon - R. De Luca

11.05-12.30 STUDY PROPOSAL BY Y-SICO MEMBER

LUNCHTIME

14.30 - 16.30 SELECTED COMMUNICATIONS: UPPER GIChairmen: A. Liboni, C. Zingaretti14.30 THE BILE ACID RECEPTOR GPBAR1 (TGR5) IS EXPRESSED IN HUMAN GASTRIC

CANCERS AND PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION IN GASTRIC CANCER CELL LINES Graziosi L.*[1], Marino E.[1], Carino A.[2], Cipriani S.[2], Donini A.[1], Fiorucci S.[2] [1]General and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia ~ perugia ~ Italy, [2]Dipartimento di Scienze Chirurgiche e Biomediche, Università degli Studi di Perugia ~ perugia ~ Italy

14.40 SEREUM C-REACTIVE PROTEIN AND GASTRIC CANCER: COULD IT BE A PROG-NOSTIC MARKER? Graziosi L., Marino E.*, Maria Cristina V., Donini A. general and Emergency Surgery, Santa Maria della Misericordia Hospital of Peru-gia ~ perugia ~ Italy

14.50 PARENCHYMAL-SPARING HEPATECTOMIES (PSH) FOR BILOBAR COLORECTAL LIVER METASTASES ARE ASSOCIATED WITH A LOWER MORBIDITY AND SIMILAR ONCOLOGICAL RESULTS: A PROPENSITY SCORE MATCHING ANALYSIS Memeo R.*[1], French Surgical Association (.F.D.C.[2] [1]Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]French Surgical Associa-tion (Association Française de Chirurgie) ~ France ~ France

15.00 PROGNOSTIC FACTORS AFTER CURATIVE RESECTIONS FOR GASTRIC CANCER: RESULTS OF A SERIES OF 534 PATIENTS Silvestri S.*[1], Deiro G.[2], Amisano M.[1], Cassine D.[2], Fop F.[3], Fronda G.[4], Satolli M.A.[5], Franchello A.[2] [1]Division of Surgery - Santo Spirito Hospital ~ Casale Monferrato (AL) ~ Italy, [2]

Department of Surgery - AOU Città della Salute e della Scienza ~ Torino ~ Italy, [3]Department of Kidney Transplantation - AOU Città della Salute e della Scienza ~ Torino ~ Italy, [4]Humanitas Gradenigo Hospital ~ Torino ~ Italy, [5]Department of Oncology - AOU Città della Salute e della Scienza ~ Torino ~ Italy

15.10 DOWNSTAGING OF LOCALLY ADVANCED PANCREATIC CANCER AFTER MULTI-MODAL TREATMENT Girelli Roberto*, Frigerio Isabella*, Giardino Alessandro* Regi Paolo*, Scopelliti Filippo*, Pederzoli Paolo*, Bassi Claudio**, Girelli R.* Casa Di Cura Pederzoli ~ Peschiera Del Garda - Verona ~ Italy

26


15.20 A RANDOMIZED PHASE II TRIAL ON NEOADJUVANT CHEMOTHERAPY IN RESECT-ABLE PANCREATIC ADENOCARCINOMA Balzano G.*[1], Zanon S.[1], Castoldi R.[1], Aleotti F.[1], Zerbi A.[2], Falconi M.[1], An-dreasi V.[1], Gianni L.[1], Nicoletti R.[1], Reni M.[1] [1]San Raffele Scientific Institute ~ Milan ~ Italy, [2]Ist. Clinico Humanitas ~ Roz-zano ~ Italy

15.30 PLASTICS AND BIDUTTOENTEROANASTOMOSIS FOR KLATSKIN BISMUTH IIIA TUMOR Kazemi Nava A.*, D’’Angelo F., De Siena M., Antolino L., Sirimarco D., Aurello P., Bersigotti L., Mariano G., Giulitti D., Ramacciato G. La Sapienza Facoltà di Medicina e Psicologia ~ Rome ~ Italy

15.40 SORAFENIB AS NEOADJUVANT THERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH VASCULAR INVASION: LUCKY CHANCE OR EFFECTIVENESS? Ceriotti M.*[1], Percivale A.[2], Cipriani F.[3], Bruzzone L.[4], Griseri G.[5], Aldrighetti L.A.[3], Pellicci R.[2] [1]università di Genova ~ Genova ~ Italy, [2]Dipartimento chirurgie, Ospedale Santa Corona ~ Pietra Ligure (SV) ~ Italy, [3]Ospedale Vita Salute San Raffaele ~ Milano ~ Italy, [4]Gastroenterologia ospedale Santa Corona ~ Pietra Ligure (SV) ~ Italy, [5]Dipartimento chirurgie, Ospedale Santa CoronaOspedale San Paolo ~ Savona ~ Italy

15.50 DiscussionDiscussants: V. Bresadola , P. Castagnoli, E. Minciotti, G. Mura, M. Simone

27


TRUMPET HALL 2

8.30 - 10.30 NEOADJUVANT THERAPY IN PANCREATIC ADENOCARCINOMAChairmen: G. Balzano, E. Corgna8.30 Clinical cases: surgery first or neoadjuvant treatment?

Clinical Case 1 Giovanni Capretti

Clinical Case 2 Gian Luca Baiocchi

9.00 Role of neoadjuvant treatment in resectable and borderline pancreatic cancer: evidences and guidelines Massimo Falconi

9.15 Which neoadjuvant treatment in pancreatic cancer? The oncologist’s doubts Nicola Silvestris

9.30 Criteria to select patients for surgery after neoadjuvant treatment Riccardo Casadei

9.40 Do we do the same? Present practice and results of surgery after neoadjuvant treatment in two high-volume centers R. Salvia, U. Boggi

Discussants: S. Alfieri, G Malleo 10.25 ABSTRACT SESSION Chairmen: R. Girelli , S. Alfieri Selected communicationsIMMUNOLOGICAL PROFILE OF SYSTEMIC EFFECTS AFTER RADIOFREQUENCY ABLATION OF LOCALLY ADVANCED PANCREATIC CANCER: STUDY DESIGN AND PRELIMINARY RESULTS Giardino A.*[1], Girelli R.[1], Frigerio I.[1], Regi P.[1], Scopelliti F.[1], Butturini G.[1], Pederzoli P.[1], Bassi C.[2] [1]Casa di Cura Pederzoli - Chirurgia Pancreatica ~ Peschiera del Garda (VR) ~ Italy, [2]

Pancreas Institute ~ Verona ~ ItalyPREDICTIVE ROLE OF INTRAOPERATIVE FROZEN SECTION IN DETECTION OF PANCREATIC FISTULA AFTER PANCREATICODUODENECTOMY: PRELIMINARY RESULTS. Silvestri S.*[4], Deiro G.[1], Amisano M.[4], Cassine D.[1], Chiusa L.[2], Fronda G.[3], Franchello A.[1], Molinaro L.[2] [1]Department of Surgery - AOU Città della Salute e della Scienza ~ Torino ~ Italy, [2]

Department of Pathology - AOU Città della Salute e della Scienza ~ Torino ~ Italy, [3]

Humanitas Gradenigo Hospital ~ Torino ~ Italy, [4]Division of Surgery - Santo Spirito Hospital ~ Casale Monferrato (AL) ~ Italy

28


SESSION 2: VIDEO (11.00 - 12.30)

Chairmen: P. Baccari, A. Zerbi ORIGINAL TECHNIQUE OF WIRSUNG-PANCREATICOGASTRIC ANASTOMOSIS AFTER PANCREATODUODENECTOMY: LOW COMPLICATION RATE IN A SINGLE CENTER EXPERIENCE IN 100 PATIENTS Bizzoca C.*, Lippolis A.S., Angarano E., Basile M.R., Vincenti L. Polyclinic of Bari ~ Bari ~ ItalyROBOT-ASSISTED SPLEEN-PRESERVING DISTAL PANCREATECTOMY FOR MUCINOUS CYSTADENOMA OF PANCREATIC NECK Authors: Marano L., Listorti C., Mazza S., Bellochi R., Patriti A. Institution: Division of Multidisciplinary Robotic Surgery, “San Matteo degli Infermi Hospital”– ASL Umbria 2, 06049, Spoleto (PG), ItalyROBOTIC LYMPHADENECTOMY DURING PANCREATODUODENECTOMY WITH FIRST SUPERIOR MESENTERIC ARTERY DISSECTION Memeo R.*[1], Pessaux P.[2] [1]Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]NHC ~ Strasbourg ~ FrancePORTAL VEIN RESECTION AND TYPE OF RECONSTRUCTION OF PORTO-MESENTERIC TRUNK FOR RADICAL SURGICAL TREATMENT OF PANCREATIC ADENO-CARCINOMA. SINGLE CENTRE EXPERIENCE Gardini A.*, Labarba G., Morgagni P., Dacapito F., Cavaliere D., Avanzolini A., Framarini M., Ercolani G. General and mininvasive Surgery ~ FORLI ~ ItalyDiscussants: P. Di Sebastiano, R. Girelli, P. Ubiali

LUNCHTIME

Selected communications: 14.30-16.30 COLORECTAL CANCER AND PERITONEAL CARCINOMATOSISChairmen: S. Bonilauri, A.L. Gaspari, S. Scabini14.30 NEXT-GENERATION SEQUENCING FOR MIRNA PROFILING OF STOOL AND PLAS-

MA SAMPLES OF PATIENTS WITH COLORECTAL CANCER OR PRECANCEROUS LESIONS Gallo G.*[1], Realis Luc A.[1], Tarallo S.[3], Cordero F.[2], Pardini B.[3], Vineis P.[4], Na-ccarati A.[3], Clerico G.[1], Trompetto M.[1] [1]Department of Colorectal Surgery - Clinica S.Rita ~ Vercelli ~ Italy, [2]Depart-ment of Computer Sciences, University of Torino ~ Torino ~ Italy, [3]Human Ge-netics Foundation ~ Torino ~ Italy, [4]School of Public Health, Imperial College of London ~ London ~ United Kingdom

14.40 EARLY COLORECTAL CANCER: IS SURGERY ALWAYS MANDATORY? Brighi M.*[1], De Siena N.[1], Vaccari S.[1], Pagano N.[2], Luppi G.[2], Cervellera M.[1], Tonini V.[1]

29


[1]Chirurgia d’Urgenza – Cervellera. Sant’Orsola-Malpighi. Università degli Studi di Bologna. ~ Bologna ~ Italy, [2]Gastroenterologia - Bazzoli. Sant’Orsola-Mal-pighi. ~ Bologna ~ Italy

14.50 PURE NOTES TOTAL MESORECTAL EXCISION (TME) FOR PATIENTS WITH RECTAL NEOPLASIA IS IT POSSIBLE TO GO ALL THE WAY UP FROM THE ANUS? D’’Alessandro A.*, Canonico G., Chouillard E. CHIPS ~ Poissy ~ France

15.00 TRANSCRIPTIONAL SIGNATURE OF PSEUDOMYXOMA PERITONEI: AN ENHANCE-MENT OF TREATMENT STRATEGY AND OUTCOME PREDICTION Vaira M.*, Robella M., Isella C., Borsano A., Mignone A., Medico E., De Simone M. Candiolo Cancer Institute, FPO-IRCCS ~ Candiolo, Torino ~ Italy

15.10 REITERATED SURGICAL CYTOREDUCTION AND HYPERTHERMIC INTRAPERITO-NEAL CHEMOTHERAPY IN PATIENTS AFFECTED BY PERITONEAL CARCINOSIS: A MULTI-CENTRIC ITALIAN EXPERIENCE Vaira M.[1], Robella M.[1], Londero A.P.[2], Bertozzi S.[3], Borsano A.[1], Santangelo A.[3], Bacchetti S.[3], De Simone M.[1], Pasqual E.M.*[3] [1]Candiolo Cancer Institute, FPO - IRCCS, Unit of Surgical Oncology, Strada Prov. 142 Km 3.95, 10060 Candiolo - Torino ~ Candiolo ~ Italy, [2]UO Ginecologia ed Ostetricia, Ospedale San Polo, AAS 2, 34074 Monfalcone (GO). ~ Monfalcone ~ Italy, [3]Advance Surgical Oncology Center, Clinic of Surgery, AOUD, Piazzale Santa Maria Misericordia, 33100 Udine,Italy. ~ Udine ~ Italy

15.20 SINGLE-PORT PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY (PIPAC) ASSOCIATED WITH SYSTEMIC CHEMOTHERAPY: A SAFE AND PROMISING STRATEGY FOR PERITONEAL CARCINOMATOSIS. Robella M.*, Vaira M., Borsano A., De Simone M. Candiolo Cancer Institute, FPO - IRCCS ~ Candiolo, Torino ~ Italy

15.30 MANAGEMENT OF MALIGNANT COLONIC POLYPS (T1). ENDOSCOPIC POLYP-ECTOMY VS SURGERY AND ANALYSIS OF PATHOLOGICAL RISK FACTORS FOR LYMPH NODE METASTASIS: A PROSPECTIVE MONOCENTRIC STUDY Parini D.*[1], Zuolo M.[1], Meggiato T.[2], Del Favero G.[2], Galeotti F.[1] [1]UOC Chirurgia generale, Ospedale Santa Maria della Misericordia ~ Rovigo ~ Italy, [2]SOC Gastroenterologia e Endoscopia Digestiva, Ospedale Santa Maria della Misericordia ~ Rovigo ~ Italy

15.40 LAPAROSCOPIC TATME FOR MID-LOW RECTAL CANCER: SHORT- AND MID-TERM RESULTS Mellano A.*, Muratore A., Marsanic P., Failla A. Candiolo Cancer Institute -IRCCs ~ Candiolo, Turin ~ Italy

Discussants: G.L. Baiocchi (Bs) G. Garulli (Riccione), M. Martinotti (CR), A. Parisi (TR)

30

TUESDAY, OCTOBER 25th 2016 - 15.00 POSTER SESSION

1. POST-RADIOTHERAPY ATYPICAL VASCULAR LESIONS AND ANGIOSARCOMAS OF THE BREAST: A COMMON MOLECULAR PATHWAY? Calderoni* S.*, Cuoghi* M., Ferrarini* R., Asioli S., Morandi L., Brotto M., Corradini A.G., Cucchi M.C., Foschini M.P. Bologna ~ Bologna ~ Italy

2. FDG PET/CT AND BREAST CANCER: SURGERY OR NEOADJUVANT CT? Invento A.*[1], Pellini F.[1], Mirandola S.[1], Grigolato D.[2], Ferdeghini M.[2], Pollini G.P.[1] [1]Breast Unit Verona USD Chirurgia Senologica ~ Verona ~ Italy, [2]UOC MEDICINA NUCLEARE VERONA ~ VERONA ~ Italy

3. PROGNOSTIC VALUE OF THE MULTIPLE MICROMETASTASES IN THE SENTINEL NODE OF BREAST CANCER ON AXILLARY LYMPH-NODE DISSECTION PROGNOSTIC CONSIDERATION. Calderoni* S.*, Cuoghi* M., Cucchi* M.C., Galluzzo* V., Monica M.T., Argazzi N., Asioli S., Foschini M.P. Bologna ~ Bologna ~ Italy

4. RESECTION OF PRIMARY LEIOMYOSARCOMA OF THE INFERIOR VENA CAVA (IVC) WITH RECONSTRUCTION: A CASE SERIES Sandrucci S.*[1], Merlo M.[2], Grignani G.[3], Lista P.[4], Verri A.[2], Pau R.[2] [1]Visceral Sarcoma Unit, City of Health and Science University Hospital ~ Torino ~ Italy, [2]Vascular surgery department, City of Health and Science University Hospital ~ Torino ~ Italy, [3]Division of Medical Oncology, Candiolo Cancer Institute-FPO- IRCCS, Candiolo ~ Torino ~ Italy, [4]Division of Medical Oncology, City of Health and Science University Hospital ~ Torino ~ Italy

5. Robot-assisted anatomic liver resection of Sg3 for hepatocellular carcinoma Authors: Listorti C., Marano L.,Spaziani A.,Bartoli A., Patriti A. Institution: Division of Multidisciplinary Robotic Surgery, “San Matteo degli Infermi Hospital”– ASL Umbria 2, 06049, Spoleto (PG), Italy

6. OESOPHAGECTOMY FOR CANCER: ANALYSES ON OUTCOMES AND INTENSIVE CARE UNIT INVOLVEMENT Puccetti F.*, Madonini M., De Pascale S., Balazova J., Lascari V., Fumagalli U. IRCCS Humanitas Research Hospital ~ Rozzano (MI) ~ Italy

7. ROBOT-ASSISTED IVOR LEWIS ESOPHAGECTOMY Pallabazzer G.*, Santi S., D’’Imporzano S., Solito B. Esophageal Surgery Unit, Department of Surgery , Azienda Ospedaliero-Universitaria Pisana ~ Pisa ~ Italy

8. CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSTIC FACTORS OF GASTRIC CANCER IN THE ELDERLY PATIENTS OVER 75 YEARS Salandini M.C.*, Gasparini G., Orsenigo E., Carlucci M. San Raffaele Hospital ~ Milan ~ Italy

31

POSTER

9. CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSTIC FACTORS OF GASTRIC CANCER IN YOUNG PATIENTS Perali C.*, Orsenigo E., Salandini M.C., Carlucci M. San Raffaele Hospital ~ Milan ~ Italy

10. FAST TRACK ITEMS COMPLIANCE IN ELDERLY GASTRIC CANCER PATIENTS: PRELIMINAR ANALYSIS OF A SINGLE CENTRE SERIES Ruspi L.*, Galli F., Peverelli C., Inversini D., Martignoni F., Di Rocco G., Boni L., Dionigi G., Rausei S. Department of Surgery - University of Insubria ~ Varese ~ Italy

11. INDOCYANINE GREEN-ENHANCED FLUORESCENCE TO EVALUATE DUODENAL STUMP PERFUSION DURING GASTRECTOMY Ruspi L.*, Galli F., Pappalardo V., Lavazza M., Boni L., Dionigi G., Rausei S. Department of Surgery - University of Insubria ~ Varese ~ Italy

12. D2 LYMPHADENECTOMY FOR GASTRIC CANCER Lavazza M.*, Ruspi L., Galli F., Martignoni F., Di Rocco G., Boni L., Dionigi G., Rausei S. Department of Surgery - University of Insubria ~ Varese ~ Italy

13. DIAGNOSTIC VALUE OF EUS IN THE SELECTION OF PATIENTS WITH GASTRIC CANCER ELIGIBLE FOR A NEOADJUVANT CHEMOTHERAPY Marra D.*[1], Corradini G.[1], Antonini F.[2] [1]General Surgery ~ Fermo ~ Italy, [2]Gastroenterology ~ Fermo ~ Italy

14. SECOND LEVEL LYMPHADENECTOMY IN GASTRIC CANCER: IS THE NUMBER OF RETRIEVED NODES CRUCIAL? Galli F.*, Ruspi L., Inversini D., Martignoni F., Di Rocco G., Dionigi G., Rausei S. Department of Surgery, University of Insubria ~ Varese ~ Italy

15. GASTRIC AND DUODENAL GIST: EMERGENCY AND ELECTIVE SURGERY Alberici L.*, Luppi G., De Siena N., Brighi M., Cervellera M., Tonini V. Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di Bologna. ~ Bologna ~ Italy

16. SURGICAL OUTCOME OF LOCALLY ADVANCED ADENOCARCINOMAS OF THE STOMACH AND GASTROESOPHAGEAL JUNCTION TREATED BY NEOADJUVANT CHEMORADIATION. Belluco C.*, Marco F., Olivieri M., Buonadonna A., Cannizzaro R., De Paoli A., Perin T., Fornasarig M., Canzonieri V., Bertola G. CRO – IRCCS, National Cancer Institute ~ Aviano ~ Italy

17. RADICAL SURGERY FOR GASTRIC CANCER IN OCTOGENARIAN PATIENTS Casella F.*[1], Sansonetti A.[1], Necozione S.[2], Cofini V.[2], Capodacqua A.[2], Verzaro R.[1] [1]GENERAL SURGERY PROGRAM, M.G. VANNINI HOSPITAL ~ ROME ~ Italy, [2]MD DEPARTMENT OF LIFE, HEALTH AND ENVIROMENTAL SCIENCES ~ L’AQUILA ~ Italy

32

POSTER

18. PRELIMINARY RESULTS OF ERAS PROTOCOL FOR GASTRIC CANCER Casella F.*, Sansonetti A., Ferroni A., Rago T., Mattia S., Verzaro R. GENERAL SURGERY PROGRAM, M.G. VANNINI HOSPITAL ~ ROME ~ Italy

19. SERUM CD26 LEVELS IN PATIENTS WITH GASTRIC CANCER: A NOVEL POTENTIAL DIAGNOSTIC MARKER Marano L.*[1], Listorti C.[1], De Luca R.[2], Di Martino N.[3], Patriti A.[1] [1]Robotic Surgery Unit - “San Matteo degli Infermi” Hospital - AUSL Umbria 2 - Spoleto (PG) ~ Spoleto (PG) ~ Italy, [2]Department of Surgical Oncology, National Cancer Research Centre - Istituto Tumori “G. Paolo II” ~ Bari ~ Italy, [3]second university of naples ~ Naples ~ Italy

20. ANALYSIS OF SAFETY AND EFFICACY OF LAPAROSCOPIC RESECTION FOR GASTROINTESTINAL STROMAL TUMOURS OF THE STOMACH AND LITTLE BOWEL Scagliarini L.*, Anania G., Fabbri N., Giaccari S., Resta G. Azienda ospedaliera universitaria di Ferrara ~ Ferrara ~ Italy

21. OVERALL AND DISEASE-FREE SURVIVAL IN PATIENTS TREATED WITH HIPEC FOR ADVANCED GASTRIC CANCER WITH PERITONEAL CARCINOMATOSIS. Montori G.*[2], Fugazzola P.[1], Coccolini F.[1], Ceresoli M.[1], Ansaloni L.[1] [1]Ospedale papa giovanni 23 ~ bergamo ~ Indonesia, [2]~ Indonesia

22. ROLE OF VOLUNTEERING FOR IMPROVING QUALITY AND PERFORMANCE IN MANAGED GASTRIC CANCER Vannelli A.*[1], Putortì A.[1], Rossi F.[1], Scolaro R.[2], Zanardo M.[1] [1]Division of Surgical Oncology Valduce Hospital ~ Como ~ Italy, [2]Division General Surgery Policlinico G Martino ~ Messina ~ Italy

23. EX VIVO LYMPHADENECTOMY DURING GASTRIC SURGERY FOR ADENOCARCINOMA: RESULT FROM A SINGLE CENTRE Graziosi L.*, Marino E., Donini A. general and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia ~ perugia ~ Italy

24. EXTENDED INTERVAL AFTER NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER: A SINGLE CENTRE EXPERIENCE Turati L.*[1], Steccanella F.[1], Russo A.A.[1], Petrelli F.[2], Rampulla V.[1], Bianco F.[1], Barni S.[2], Sgroi G.[1] [1]Surgical Oncology Unit - Treviglio Hospital ~ Treviglio (BG) ~ Italy, [2]Clinical Oncology Unit - Treviglio Hospital ~ Treviglio (BG) ~ Italy

25. NODAL STAGING IN COLORECTAL CANCER: COMPARISON BETWEEN EMERGENCY AND ELECTIVE SURGERY Gasparini G.*, Luperto M., Orsenigo E., Carlucci M. San Raffaele Hospital ~ Milano ~ Italy

33

POSTER

26. LAPAROSCOPIC TATME AND COLO-ANAL ANASTOMOSIS FOR RECTAL CANCER IN AN OBESE PATIENT Mellano A.*, Muratore A., Marsanic P., Failla A. Candiolo Cancer Institute -IRCCs ~ Candiolo, Turin ~ Italy

27. TREATMENT OF A LATE RECTAL STUMP INSUFFICIENCY AFTER HARTMANN’S PROCEDURE WITH THE VACUUM ASSISTED CLOSURE SYSTEM: IS IT WORTH? Sandrucci S.*, Mobiglia A., Verra M., Esposito L. Visceral Sarcoma Unit, University of Turin ~ torino ~ Italy

28. EFFECTIVENESS OF A BRIEF RISK SCREENING TOOL IN DETECTING FRAILTY IN ELDERLY PATIENTS UNDERGOING EMERGENCY ABDOMINAL SURGERY. A PILOT STUDY. Zattoni D.*[2], Cervellera M.[2], Calogero P.[1], Galetti F.[1], Garutti A.[1], Bacchi Reggiani M.L.[3], Tonini V.[2] [1]Geriatrics Policlinico S.Orsola-Malpighi ~ Bologna ~ Italy, [2]General Surgery - Policlinico S. Orsola-Malpighi ~ Bologna ~ Italy, [3]Statistics - Policlinico S. Orsola-Malpighi ~ Bologna ~ Italy

29. TRANSANAL NOTES TOTAL MESORECTAL EXCISION (TME) IN PATIENTS WITH RECTAL CANCER: IS ANATOMY BETTER PRESERVED? Canonico G.*, D’’Alessandro A., Chouillard E. CHIPS ~ Poissy ~ France

30. PLACEMENT OF SELF-EXPANDABLE METAL STENTS AS A BRIDGE TO SURGERY: IMPACT ON POST-OPERATIVE OUTCOME Vaccari S.*, Cervellera M., Pirrera B., Alberici L., Brighi M., Belinga Atangana A.G., Picariello E., Tonini V. Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di Bologna. ~ Bologna ~ Italy

31. MULTIMODALITY APPROACH TO THE EXTRAPERITONEAL RECTAL CANCER Pulighe F.*[1], Panagiotis P.[2], Scognamillo F.[2], Marrosu A.[2], Argenio G.[1], Balestra F.[1], De Nisco A.[1], Guerra F.[1], Attene F.[2], Cruccu A.[1] [1]San Francesco Hospital of Nuoro ~ Nuoro ~ Italy, [2]Department of Surgical Microsurgical and Medical Sciences, University of Sassari, V.le San Pietro 43B, 07100, Sassari ~ Sassari ~ Italy

32. TRANSANAL TOTAL MESORECTAL EXCISION (TATME): SURGICAL TECHNIQUE DESCRIPTION Persiani R.*, Biondi A., Santullo F., Pennestrì F., Tirelli F., Sicoli F., Lirosi M.C., Fico V., D’’Ugo D. Catholic University of Sacred Heart ~ Rome ~ Italy

34

POSTER

33. INTRACORPOREAL ANASTOMOSIS AFTER LAPAROSCOPIC RIGHT COLECTOMY. GUILTY OR NOT GUILTY? A SYSTEMATIC REVIEW WITH METANALYSIS OF LITERATURE. Manigrasso M.*, Di Lauro K., Milone M. University of Naples “Federico II” ~ Naples ~ Italy

34. NEOPLASTIC INTUSSUSCEPTION: A RARE CAUSE OF SMALL BOWEL OBSTRUCTION Casati A.*, De Siena N., Alberici L., Pirrera B., Cervellera M., Tonini V. Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di Bologna. ~ Bologna ~ Italy

35. RESPONSE TO NEOADJUVANT CRT FOR DISTAL RECTAL CANCER: OUR EXPERIENCE Sorbo G.*, Pirrera B., Vaccari S., De Siena N., Luppi G., Cervellera M., Tonini V. Chirurgia d’Urgenza - Cervellera. Sant’Orsola-Malpighi. Università degli Studi di Bologna. ~ Bologna ~ Italy

36. ROBOTIC TOTAL MESORECTAL EXCISION WITH DAVINCI XI SYSTEM Misitano P.*, Formisano G., Giuliani G., Krizzuk D., De Luca M., Salvischiani L., Bianchi P.P. MISERICORDIA HOSPITAL ~ GROSSETO ~ Italy

37. ROBOTIC RIGHT COLECTOMY WITH COMPLETE MESOCOLIC EXCISION PERFORMED BY A NOVICE SURGEON Giuliani G.*, Formisano G., Misitano P., Coratti F., De Luca M., Krizzuk D., Salvischiani L., Bianchi P.P. MISERICORDIA HOSPITAL ~ Grosseto ~ Italy

38. ELEVATED PLATELET COUNT IS A NEGATIVE PREDICTIVE FACTOR FOR PATHOLOGICAL TUMOR RESPONSE AND LONG-TERM ONCOLOGIC OUTCOME IN LOCALLY ADVANCED RECTAL CANCER UNDERGOING PREOPERATIVE CHEMORADIATION Forlin M.*[1], Rega D.[2], Olivieri M.[1], Bertola G.[1], Buonadonna A.[1], Cannizzaro R.[1], Canzonieri V.[1], De Paoli A.[1], Pace U.[2], Scala D.[2], Del Rio P.[2], Belluco C.[1] [1]CRO – IRCCS, National Cancer Institute ~ Aviano ~ Italy, [2]Fondazione G.Pascale - IRCCS ~ Napoli ~ Italy

39. CARCINOMA OF THE SPLENIC FLEXURE: WHAT SURGICAL TREATMENT. Rega D.*, Pace U., Scala D., Ruffolo F., Sassaroli C., Delrio P. Colorectal Surgical Oncology - istituto nazionale per lo studio e la cura dei tumori “Fondazione Giovanni Pascale” IRCCS ~ Napoli ~ Italy

40. RECENT ADVANCES IN NEOADJUVANT THERAPY FOR RECTAL CANCER Panier Suffat L.*, Piva C., Sciacero P., Bombaci S., Scapino B., Bertotti L., Barengo E., Rosato L. Giorgio Vellani S.C.O. Oncologia. ASL TO 4 ~ Ivrea ~ Italia

35

POSTER

41. RECTAL CANCER IN URGENCY, WHAT’S THE STRATEGY? Panier Suffat L.*, Bertotti L., Piva C., Sciacero P., Scapino B., Contratto R., Rosato L. Giorgio Vellani S.C.O. Oncologia. ASL TO 4 ~ Ivrea ~ Italia

42. TREATMENT OF COLORECTAL CANCER: MULTIDISCIPLINAY APPROACH Scagliarini L., Anania G., Marino S.*, Marchitelli I., Resta G. Azienda ospedaliera universitaria di Ferrara ~ Ferrara ~ Italy

43. TOTALLY LAPAROSCOPIC RIGHT COLECTOMY WITH COMPLETE MESOCOLON EXCISION Lucchi A.*, Berti P., Gabbianelli C., Alagna V., Guerra M., Corbucci Vitolo G., Vandi F., Garulli G. AUSL della Romagna ~ Riccione ~ Italy

44. LAPAROSCOPIC RIGHT HEMICOLECTOMY WITH INTRACORPOREAL ANASTOMOSIS. HOW DO I DO IT Simonelli V.*, Rijkaerts M.

45. DOES PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMORADIATION IN RECTAL CANCER INFLUENCE EARLY SURGICAL OUTCOME? THE “G. PAOLO II” CANCER RESEARCH CENTRE EXPERIENCE. De Luca R.[1], Caliandro C.[1], Ruggieri E.[1], Lomonaco R.[1], Rucci A.[1], Ammendola M.*[2], Nardone A.[1], Simone M.[1] [1]National Cancer Research Centre “G.Paolo II” Istituto Tumori ~ BARI ~ Italy, [2]

Clinical Surgery Unit.University of “Magna Grecia” ~ Catanzaro ~ Italy

46. SIDE-TO-SIDE STAPLED COLORECTAL ANASTOMOSIS IN LEFT LAPAROSCOPIC COLECTOMY: EXPERIENCE IN A SINGLE CENTER Gennai A.*, Muzio E., Dova L., Francone E., Feleppa C., Bianchi C., Falco E., Berti S. Ospedale S.Andrea ASL 5 ~ La Spezia ~ Italy

47. PROGNOSTIC VALUE OF PERITONEAL CARCINOEMBRYONIC ANTIGEN IN PERITONEAL LAVAGE IN PATIENTS AFFECTED BY COLON CANCER Graziosi L., Marino E., Bartolini V.*, Donini A. general and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia ~ perugia ~ Italy

48. RESECTABILITY AFTER NEOADJUVANT THERAPY FOR PRIMARY UNRESECTABLE PANCREATIC ADENOCARCINOMA Beltrame V.*[1], Gruppo M.[1], Patanè G.[1], Paladina I.[2], Crivellari G.[2], Valmasoni M.[1], Spolverato Y.C.[1], Pozza G.[1], Sperti C.[1] [1]Department of Surgery, Oncology and Gastroenterology, 3rd Surgical Clinic, University of Padua ~ Padova ~ Italy, [2]Veneto Institute of Oncology (IOV) ~ Padova ~ Italy

36

POSTER

49. IRREVERSIBLE ELECTROPORATION AS TREATMENT OF LOCALLY ADVANCED AND AS COMPLEMENT OF SURGERY IN BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA Marsanic P.*, Mellano A., Sottile A., De Simone M. IRCCs ~ Candiolo ~ Italy

50. SURGICAL AND PATHOLOGICAL OUTCOME AFTER DOWNSTAGING IN PANCREATIC CANCER INTRODUCTION Frigerio I.*[1], Pulvirenti A.[2], Giardino A.[1], Paolo R.[1], Girelli R.[1], Scopelliti F.[1], Butturini G.[1] [1]Casa di Cura Pederzoli ~ Peschiera del Garda ~ Italy, [2]Pancreas Institute ~ Verona University, Verona ~ Italy

51. SELECTING PATIENTS FOR SURGERY AFTER PRIMARY CHEMOTHERAPY FOR NON-METASTATIC PANCREATIC ADENOCARCINOMA Nobile S.*, Reni M., Zanon S., Nicoletti R., Andreasi V., Castoldi R., Partelli S., Crippa S., Falconi M., Balzano G. San Raffele Scientific Institute ~ Milan ~ Italy

52. PORTAL VEIN RECOSTRUCTION DURING WHIPPLE PROCEDURE D’’Angelo F., Sirimarco D.*, Antolino L., Aurello P., Petrucciani N., Valabrega S., Kazemi Nava A., Nigri G., Ramacciato G. Sapienza Università di Roma - Azienda Ospedaliera Sant’Andrea ~ Roma ~ Italy

53. NEOADJUVANT PROTOCOLS IN RESECTABLE, BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC CANCER: WHERE ARE WE NOW? Antolino L.*, Kazemi Nava A., Sirimarco D., De Siena M., Aurello P., Ramacciato G., D’’Angelo F. Università Sapienza, Facoltà di Medicina e Psicologia, Dipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale ~ Roma ~ Italy

54. PARIETAL CELL GASTRIC CARCINOMA – AN EXTREMELY RARE ENTITY. TWO NEW CASES WITH FIRST-TIME ASSESSMENT AND RECORDING OF ABSENCE OF HER2 EXPRESSION AND LITERATURE REVIEW V. Mavroeidis1, M. Demonakou2, K. Kandilaris2, Z. Almpanis2, K. Alexiou1, D. Matthioudakis1, F. Menikou3, N. Economou1 1st Surgical Department, Sismanogleio General Hospital, Athens, Greece Department of Pathology, Sismanogleio General Hospital, Athens, Greece 2nd Surgical Department, Sismanogleio General Hospital, Athens, Greece

55. STRATEGIA TERAPEUTICA E RISULTATI NEL CARCINOMA COLECISTICO INCIDENTALE Frena A.*[1], Patauner S.[2], Fissneider B.[2], Martin F.[2] [1]Chirurgia Epatobiliare ~ Bolzano ~ Italy, [2]Chirurgia Generale ~ Bolzano ~ Italy

37

POSTER

56. EFFECT OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS SUBMITTED TO LIVER RESECTION FOR COLORECTAL LIVER METASTASES. Bianchi G.*, Lamecchi L., Iaria M., Dalla Valle R. Chirurgia generale e dei trapianti d’organo ~ Parma ~ Italy

57. MINIMALLY INVASIVE (MI) VS OPEN PARENCHYMAL-PRESERVING LIVER RESECTIONS IN THE SEGMENTS (SG) 7 AND 8. Listorti C.*[1], Mazza S.[1], Bartoli A.[2], Bellochi R.[2], Spaziani A.[2], Marano L.[2], Patriti A.[2] [1]Università di Perugia ~ Perugia ~ Italy, [2]Division of Robotic Surgery, Department of Surgery. ASL Umbria 2. San Matteo degli Infermi Hospital, Spoleto. Italy ~ Spoleto ~ Italy

58. MAJOR HEPATECTOMY FOR COLORECTAL LIVER METASTASES IN PATIENTS AGED OVER 80: A PROPENSITY SCORE MATCHING ANALYSIS Memeo R.*[1], French Surgical Association (.F.D.C.[2] [1]Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]French Surgical Association (Association Française de Chirurgie) ~ France ~ France

59. MARGIN STATUS IS STILL AN IMPORTANT PROGNOSTIC FACTOR IN HEPATECTOMIES FOR COLORECTAL LIVER METASTASES: A PROPENSITY SCORE MATCHING ANALYSIS Memeo R.*[1], French Surgical Association (.F.D.C.[2] [1]Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]French Surgical Association (Association Française de Chirurgie) ~ France ~ France

60. LAPAROSCOPIC RIGHT HEPATECTOMY AFTER TACE AND PVE FOR HCC Memeo R.*[1], Pessaux P.[2] [1]Ospedale “F.Miulli” ~ Acquaviva delle Fonti ~ Italy, [2]NHC ~ Strasbourg ~ France

61. LAPAROSCOPIC RIGHT HEPATECTOMY FOR COLORECTAL METASTASES Giuliante F.*, Ardito F., Coppola A., Panettieri E. Catholic University, Hepatobiliary Surgery Unit ~ Rome ~ Italy

62. INFLAMMATORY MARKERS AS PROGNOSTIC FACTORS OF SURVIVAL IN TACE PATIENTS Rebonato A.*[1], Maiettini D.[1], Graziosi L.[2], Marino E.[2], Donini A.[2] [1]radiology Section of university of Perugia ~ perugia ~ Italy, [2]general and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia ~ perugia ~ Italy

38

POSTER

63. A CASE OF STERNAL CHONDROSARCOMA: SOFT TISSUE, AND SKELETAL DIAFRAGMATIC DEFECT RECONSTRUCTION WITH A DOUBLE POLYPROPYLENE / EPTFE PROSTHESIS Sandrucci S.*[1], Bruna M.C.[2], Mossetti C.[2] [1]Visceral sarcoma Unit, City of Health and Science University Hospital ~ Torino ~ Italy, [2]Thoracic Surgery Department, city of Health and Science University Hospital ~ Torino ~ Italy

64. SYNCHRONOUS PRESENTATION OF CANCER IN THE LACRIMAL AND SALIVARY GLANDS – ONCOLOGICAL ASPECTS V. Mavroeidis1, P. Chatzimpaloglou2, F. Menikou3, F. Saffioti4 1stSurgical Department, Sismanogleio General Hospital, Athens, Greece Ophthalmologist, Athens, Greece 2nd Surgical Department, Sismanogleio General Hospital, Athens, Greece Department of Clinical and Experimental Medicine, University Hospital of Messina, Messina, Italy

65. INTRAOPERATIVE ADHESIONS DEVELOPING DURING CLOSED-ABDOMEN HIPEC Lotti M.*, Giulii Capponi M., Ansaloni L., Frigerio L. Ospedale Papa Giovanni XXIII ~ Bergamo ~ Italy

66. NEOADJUVANT CHEMOTHERAPY-RELATED LEUKOPOENIA AS A BIOMARKERS PREDICTING SURVIVAL OUTCOMES IN LOCALLY ADVANCED CERVICAL CANCER Bogani G.*, Ditto A., Martinelli F., Signorelli M., Raspagliesi F., Lorusso D. National Cancer Institute ~ Milan ~ Italy

67. TRANSANAL TOTAL MESORECTAL EXCISION AFTER NEOADJUVANT THERAPY FOR RECTAL CANCER: PRELIMINARY SHORT-TERM ONCOLOGICAL RESULTS. Cossu A.*, Elmore U., Vignali A., De Nardi P., Maggi G., Lemma M., Parise P., Rosati R. Department of Gastrointestinal Surgery, San Raffaele Scientific Institute, University Vita Salute ~ Milano ~ Italy

68. MINIMALLY INVASIVE SURGICAL APPROACH FOR RADICALIZATION OF INCIDENTAL GALLBLADDER NEOPLASM: SAFETY, FEASIBILITY AND SHORT TERM OUTCOMES Garritano S.*[1], Spampinato M.G.[2] [1]Policlinico Umberto I ~ Roma ~ Italy, [2]Policlinico Abano Terme ~ Abano Terme ~ Italy

69. LAPAROSCOPIC LIVER RESECTIONS: A SINGLE CENTRE EXPERIENCE Bizzoca C.*, Maselli E., Vincenti L. Polyclinic Hospital ~ Bari ~ Italy

70. LAPAROSCOPIC HARTMANN’S PROCEDURE ASSOCIATED WITH RIGHT NEPHRECTOMY IN A 78 YEAR- OLD MAN WITH SYNCHRONOUS RECTAL CARCINOMA AND PAPILLARY RENAL CANCER. Gennai A.*, Muzio E., Francone E., Falco E., Feleppa C., Berti S. POLL 5 ~ La Spezia ~ Italy

39

POSTER

71. VOLUMINOUS JEJUNUM’S SARCOMAOTID CARCINOMA: LAPAROSCOPIC RESECTION OF LOCALLY ADVANCED MISSING PRIMITIVE LESION. Gennai A.*, Muzio E., Dova L., Francone E., Feleppa C., Bianchi C., Falco E., Berti S.S.Andrea Hospital POLL-ASL5 ~ La Spezia ~ Italy

72. FEASIBILITY AND SAFETY OF ROBOTIC COLORECTAL CANCER SURGERY IN ELDERLIES: A MATCHED CASE-CONTROL STUDY FROM A SINGLE CENTER Graziosi L., Marino E.*, Zavagno V., Bartolini V., Donini A. General and Emergency Surgery, Santa Maria della Misericordia Hospital of Perugia ~ perugia ~ Italy

40

GENERAL INFORMATION

CONFERENCE VENUE Hotel Giò Wine e Jazz Area a Perugia Via R. D’Andreotto, 19 06124 Perugia (PG)Tel. 39 075 [email protected]

The Hotel is in the city centre of Perugia, 1 km far away from the railway station, and 200 mt from the minimetrò station. You reach the historic centre in 5 minutes by minimetrò. From Hotel Giò you can reach the historic centre in 5 minutes by car or in 20 minutes on foot.

SICO SECRETARIAT and ORGANIZING SECRETARIAT Two distinct secretariats will be at the disposal of the conference participants.The Organizing Secretariat will be at the disposal of the conference participants at Giò Hotel starting from 10.00 am of 23 October 2016 and over the following days until the end of the conference. The SICO Secretariat is at the disposal of MEMBERS to answer any enquiry for societal information, to check and settle their membership fee; it will also be available to accept new memberships.Registration with the 2nd International Conference of Surgical Oncology is mandatory and will entitle to: attend the scientific sessions of 23/24/25 October, receive a confer-ence set, pocket lunch and coffee breaks as planned, attendance certificate

OVER-40 SICO MEMBERS (up to date with the payment of the 2016 membership fee € 100.00) *

Free of charge

UNDER-40 SICO SPECIALIZING MEMBERS (up to date with the payment of the 2016 membership fee € 50.00) *

Free of charge

GIRCS MEMBERS (up to date with the payment of the 2016 membership fee)

Free of charge

NON-SICO MEMBERS € 250.00Specializing medicine doctor ** Free of chargeMedicine Student*** Free of charge

Membership fees, including 22% VAT

NOTES:*The 2nd International Conference of Surgical Oncology is free of charge for SICO MEMBERS up to date with the payment of the 2016 membership fee. However, they will still have to send the Conference registration form to register. To become members please visit the website www.sicoonline.org. ** Specializing medicine doctors whose work will be selected for submission at the plenary session are re-quired to become members (€ 50.00); ***Please send the certificate of enrolment with your University CourseCANCELLATION POLICY: The membership fee may only be reimbursed if cancellation is notified to the Organiz-ing Secretariat not later than 15 JULY 2016.

41

GENERAL INFORMATION

SICO Members MeetingThe SICO Members Meeting will be held on Monday the 24th of October at the Town Hallof Giò Hotel from 6.30 pm to 7.30 pm

PRESENTERSAt least two of the Presenters of the selected communications (as either oral presenta-tions or posters) should be members of the Italian Society of Oncological Surgery and up to date with the payment of the 2016 membership fee.

SCIENTIFIC INFORMATIONThe Congress will include parallel sessions.

SHOWINGSOnly the showing of Personal Computer images is accepted: traditional slide projectors will not be installed and the use of personal PCs is not allowed. The rooms are equipped with a video-projector connected to a Personal Computer for the presentation of the works. The relevant files shall be prepared on Power Point 2000 and delivered at least 2 hours before the beginning of the session on a pen drive to the computer centre.The computer centre will be network connected to the conference rooms: all the screen-ings will be automatically forwarded to the right room.

GUIDELINES FOR CHAIRMEN AND SPEAKERSChairmen shall:- be in the room at least 10 minutes before the beginning of the session;- make sure that the session and the presentations remain within the allotted times;Speakers shall:- identify the room where the session is held in due time;- hand in the visuals of their presentation, if possible, at least 2 hours before the begin-

ning of the session to the computer centre- be in the room at least 10 minutes before the beginning of the session.

CME CREDITSThe event of 24/25 October will receive single accreditation from the Ministry of Health for the following professions:Medicine Doctors-Surgeons reference subjects: general surgery; gastroenterology; in-ternal medicine; oncology; radiotherapy; obstetrics and gynaecology; radiodiagnostics; nurses and Biologists.An attendance sheet will be signed when entering and leaving the room and credits will only be certified if the attendance time will be the actual set time for the event and if the final test to check the learning level will be passed.

42

GENERAL INFORMATION

The CME credit certification will be sent by e-mail after completing the set procedures.The CME Provider is Kassiopea Group, recognized by AGENAS under number 305.

Attendance certificatesAt the end of the Conference all duly registered attendants will receive an attendance certificate. Certificates will only be given at the end of the sessions, also in case of late closing

BadgesAdmission to the conference venue, the exhibition area and the scientific sessions will only be possible if in possession of the bar-code badge given by the Organizing Secre-tariat at the time of registration.The badge is a personal document and shall be shown to the controlling staff. It is the only valid document to collect the attendance certificate and the only way to receive credits.

AmendmentsThe Scientific Secretariat and the Organizing Secretariat reserve the right to make all the necessary amendments to the programme which are deemed necessary for technical and/or scientific reasons.

43

SPONSORS

PLATINUM SPONSOR

GOLD SPONSOR

SILVER SPONSOR

SOCIETÀ ITALIANA DI CHIRURGIA ONCOLOGICA Italian Society of Surgical Oncology, ESSO affiliated

ORGANIZING SECRETARIAT and NATIONAL SECRETARIAT SICO

Via Stamira 10 09123 CagliariTel. 070651242 Fax 070656263 antonellamurru@kassiopeagroup.comwww.sicoonline.orgwww.kassiopeagroup.com